The Hedgehog pathway as targetable vulnerability with 5-azacytidine in myelodysplastic syndrome and acute myeloid leukemia

BACKGROUND: Therapy and outcome for elderly acute myeloid leukemia (AML) patients has not improved for many years. Similarly, there remains a clinical need to improve response rates in advanced myelodysplastic syndrome (MDS) patients treated with hypomethylating agents, and few combination regimens...

Descripción completa

Detalles Bibliográficos
Autores principales: Tibes, Raoul, Al-Kali, Aref, Oliver, Gavin R, Delman, Devora H, Hansen, Nanna, Bhagavatula, Keerthi, Mohan, Jayaram, Rakhshan, Fariborz, Wood, Thomas, Foran, James M., Mesa, Ruben A., Bogenberger, James M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615363/
https://www.ncbi.nlm.nih.gov/pubmed/26483188
http://dx.doi.org/10.1186/s13045-015-0211-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615363/
https://www.ncbi.nlm.nih.gov/pubmed/26483188
http://dx.doi.org/10.1186/s13045-015-0211-8

Ejemplares similares